Pioneering the Next Breakthrough in Durable and Potent RNA Therapeutics for Patients

The field of next generation RNA therapeutics continues to progress towards clinical translation, with enormous investments and collaborations, such as Orbital Therapeutics’ recent $270 million Series A financing.

The 3rd Next Generation RNA Therapeutics Summit returns to cover the depth and breadth of the next of generation RNAs, including circular RNA, self-amplifying RNA (saRNA) and beyond from discovery to clinic and towards scalable manufacturing, unlocking the huge therapeutic and commercial potential of this emerging class of modalities.

Join 120+ expert leaders in Discovery, R AND D, Engineering, Preclinical Translation and CMC from the key stakeholders pioneering advances in RNA technologies and continue to fast-track these next generation therapies into the clinic, and towards patients faster.

Time: 9:00 AM – 5:00 PM

Venue details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices: USD 2999.00 – USD 5097.00

Speakers: Anthony Saleh, Co-founder and Chief Executive Officer, MiRecule Inc., and more